Clinical trial
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of KQ-791 in Subjects With Type 2 Diabetes
NCT02445911 is registered in ClinicalTrials.gov with Kaneq Bioscience Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of KQ-791 in Subjects With Type 2 Diabetes
- Lead sponsor
- Kaneq Bioscience Limited
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 30, 2015
- Completion date
- February 29, 2016
- Enrollment
- 81 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.